anitocabtagene autoleucel
anitocabtagene autoleucel: 1 clinical trial tracked.
anitocabtagene autoleucel evidence translation
What we can confirm
1 tracked trial
No verified listed developer
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about anitocabtagene autoleucel, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trials (1)
A Phase 3, Randomized, Open-Label Study to Compare the Efficacy and Safety of Anitocabtagene Autoleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Multiple Myeloma
Primary endpoint: Progression-Free Survival (PFS)
InterventionalRandomizedopen452 enrolledStarted 2024-08Completion 2031-0750 sites · Australia, United StatesKite, A Gilead Company